Skip to main content
Clinical Trials/ACTRN12609000713291
ACTRN12609000713291Terminated未知

Cerebral palsy and electrical stimulation - does stimulation of the gastrocnemius muscle pre- and post-botulinum toxin A injection for dynamic equinus facilitate greater uptake of the toxin when measured by clinical examination and 3-D gait analysis?

Women's and Children's Hospital0 sites50 target enrollmentStarted: August 18, 2009Last updated:
Conditions

Trial Snapshot

Phase
未知
Status
Terminated
Sponsor
Enrollment
50

Study Overview

Brief Summary

No summary available.

Study Design

Study Type
Interventional
Allocation
Randomised controlled trial
Primary Purpose
Treatment
Masking
Blinded (masking used)

Eligibility Criteria

Ages
4 Years to 12 Years (—)
Sex
All

Inclusion Criteria

  • 1. Children between the ages of 4 and 12 years with a confirmed diagnosis of spastic hemiplegic or spastic diplegic cerebral palsy (CP)
  • 2. Planned injection of gastrocnemius muscle for the treatment of dynamic equinus deformity
  • 3. Walking ability described by classification at Gross Motor Functional Classification System (GMFCS) levels one to three (walks independently or with assistive devices)
  • 4. Ongoing participation in a community-based therapy programme.

Exclusion Criteria

  • 1. Previous lower limb surgery involving the calf and/or hamstring
  • 2. Use of botox A in the calf muscle within the last six months
  • 3. Inability to follow a single stage command
  • 4. Inability to walk along a 10m walk way for a total of five trials
  • 5. Presence of fixed muscle contractures.
  • 6. Casting post-botox injection

Investigators

Sponsor
Women's and Children's Hospital

Similar Trials